2018
DOI: 10.1016/j.biologicals.2018.01.005
|View full text |Cite
|
Sign up to set email alerts
|

Enhanced chondrogenesis differentiation of human induced pluripotent stem cells by MicroRNA-140 and transforming growth factor beta 3 (TGFβ3)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

2
12
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 21 publications
(15 citation statements)
references
References 39 publications
2
12
0
1
Order By: Relevance
“…Immunofluorescence staining confirmed the presence of cells, positively stained for NANOG, but after a prolonged time of differentiation, their amount decreased. A similar observation was noticed in several iPSC cell-based protocols [24,30,40,41]. Further, we investigated how those conditions and proposed changes will influence the chondrogenic differentiation process via the analysis of the key role gene regulators of chondrogenesis such as FGFR3, SMAD3, NCAM1 , and CDH2 .…”
Section: Discussionsupporting
confidence: 68%
“…Immunofluorescence staining confirmed the presence of cells, positively stained for NANOG, but after a prolonged time of differentiation, their amount decreased. A similar observation was noticed in several iPSC cell-based protocols [24,30,40,41]. Further, we investigated how those conditions and proposed changes will influence the chondrogenic differentiation process via the analysis of the key role gene regulators of chondrogenesis such as FGFR3, SMAD3, NCAM1 , and CDH2 .…”
Section: Discussionsupporting
confidence: 68%
“…These cells have several limitations that introduce induced pluripotent stem cells (iPSCs), which could be derived from epithelial cells with overexpression of the four transcription factors, which are specifically for embryonic stage (Ardeshirylajimi, ; Takahashi & Yamanaka, ). These iPSCs can be differentiated into neurons (Salimi, Nadri, Ghollasi, Khajeh, & Soleimani, ), heart muscle (Takahashi et al, ), cartilage (Mahboudi et al, ), bone (Ardeshirylajimi & Soleimani, ), hepatocytes (Mahmoodinia Maymand et al, ), and insulin producing cells (Mansour et al, ). These cells have the same differentiation potential as that of embryonic stem cells (ESCs), but without its ethical issues, and as these cells are taken from the patient themselves, the rejection percentage of the transplant is zero; also, its potential is not age‐dependent and is increased in adult stem cells (Hwang et al, ; Jung, ).…”
Section: Introductionmentioning
confidence: 99%
“…These cells have several limitations that introduce induced pluripotent stem cells (iPSCs), which could be derived from epithelial cells with overexpression of the four transcription factors, which are specifically for embryonic stage (Ardeshirylajimi, 2017;Takahashi & Yamanaka, 2006). These iPSCs can be differentiated into neurons (Salimi, Nadri, Ghollasi, Khajeh, & Soleimani, 2014), heart muscle (Takahashi et al, 2007), cartilage (Mahboudi et al, 2018), bone (Ardeshirylajimi & Soleimani, 2015), hepatocytes (Mahmoodinia Maymand et al, 2018), and insulin producing cells (Mansour et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“… 17 MiR-140 has also been validated to enhance chondrogenesis differentiation of human iPSCs with transforming growth factor beta 3 (TGFβ3). 18 …”
Section: Discussionmentioning
confidence: 99%